Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Profit After Tax (2020 - 2025)

Historic Profit After Tax for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to -$7.1 million.

  • Bolt Biotherapeutics' Profit After Tax rose 5292.57% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.7 million, marking a year-over-year increase of 3442.27%. This contributed to the annual value of -$63.1 million for FY2024, which is 878.51% up from last year.
  • Bolt Biotherapeutics' Profit After Tax amounted to -$7.1 million in Q3 2025, which was up 5292.57% from -$8.6 million recorded in Q2 2025.
  • In the past 5 years, Bolt Biotherapeutics' Profit After Tax ranged from a high of -$7.1 million in Q3 2025 and a low of -$27.2 million during Q4 2021
  • Moreover, its 5-year median value for Profit After Tax was -$18.0 million (2023), whereas its average is -$17.8 million.
  • Per our database at Business Quant, Bolt Biotherapeutics' Profit After Tax plummeted by 13392.66% in 2021 and then skyrocketed by 5960.84% in 2025.
  • Bolt Biotherapeutics' Profit After Tax (Quarter) stood at -$27.2 million in 2021, then increased by 26.37% to -$20.0 million in 2022, then rose by 10.47% to -$17.9 million in 2023, then rose by 10.99% to -$15.9 million in 2024, then skyrocketed by 55.17% to -$7.1 million in 2025.
  • Its last three reported values are -$7.1 million in Q3 2025, -$8.6 million for Q2 2025, and -$11.0 million during Q1 2025.